MariMed Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRMD | LABS.TO | INM | PLTH.CN | ACB | TGIF.CN | |
|---|---|---|---|---|---|---|
| Market cap | 24.63M | 29.90M | 9.61M | 35.21M | 331.74M | 2.60M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -2.0 | -7.0 | -0.3 | -1.0 | -47.6 | — |
| Price/book | 0.5 | 0.8 | -8.0 | 0.6 | 0.9 | -0.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −56.76% | 0.00% | +2.64% | −58.82% | +20.18% | −50.00% |
| Today | +27.08% | +16.67% | +4.17% | −4.55% | +1.55% | −50.00% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All MRMD news ›MariMed Stockholders Approve Proposed Reverse Stock Split
--MariMed Inc., a leading multi-state cannabis operator focused on improving lives every day, today announced that the Company’ s Stockholders approved a proposed reverse stock split of the Company’ s common stock at a Special Meeting of…
MariMed Announces Third Quarter 2026 Earnings Date
Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch RTX…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com2
- globenewswire.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.